Breathing low-oxygen air in short bursts for mild cognitive impairment
Tests intermittent hypoxia training in people with mild cognitive impairment and memory problems.
Key facts
- Who runs it
- University of North Texas Health Science Center
- Where
- Fort Worth, United StatesSee the site
- Trial code
- Registry title
- IHT for Mild Cognitive Impairment
- Status
- Recruiting
- People taking part
- 66 people, planned
- Started
- 27 Feb 2023
- Planned end
- 30 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- IHT Treatment
- Sham-IHT Control
- Record updated
- 29 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 to 79 with mild cognitive impairment (MCI), meaning mild memory or thinking problems. It tests breathing air with less oxygen in short bursts (intermittent hypoxia training) for up to 12 weeks.
- Age
- 55 to 79 years
- Sex
- Men and women. Women must be past menopause.
- Disease stage
- Diagnosed with mild cognitive impairment (MCI). People with Alzheimer's dementia, or with MMSE <20 and/or CDR ≥1, cannot join. Any long-term conditions must be controlled and stable for at least 6 months.
- Earlier treatment
- People who took part in a hypoxia training study before cannot join. People who lived more than two months above 5000 ft. in the past 3 years cannot join.
- Biomarker or test result
- Blood oxygen level (arterial oxygen saturation) at or above 95% and brain tissue oxygen level at or above 50% at rest.
Main reasons for not taking part
- Alzheimer's dementia or trouble with daily activities on your own
- Depression now
- Uncontrolled long-term conditions, such as blood pressure over 150/90 mmHg on medicine, heart rhythm problems, cancer or kidney failure
- Severe head injury, brain injury or stroke
- Metal implants, fear of closed spaces or of the facemask
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Adult men and women ages 55 to 79 years old who have been diagnosed with MCI
- Must be willing to be assigned to either group: treatment or sham-treatment control
- Able to pay multiple visits to the lab for the proposed assessments
- Able to breathe moderately hypoxic air via an air-cushioned, disposable facemask
- To have controlled stabilized chronic conditions of at least 6 months duration, such as hypertension, coronary artery disease, diabetes or metabolic disease, chronic bronchitis, degenerative osteoporosis or arthritis and/or other aging-related chronic conditions
- Must be depression-free at the time of enrollment
- Must have arterial oxygen saturation at or above 95% and cerebral tissue oxygenation at or above 50% at rest
- Woman subject must be post-menopausal
Who cannot take part
- Expecting any major surgery or transplant
- Have any metallic implants or who are claustrophobic
- Currently participating in any interventional study and/or have been previously exposed to hypoxia, such as residing more than two months at altitudes above 5000 ft. within the past 3 years or previously participated in a hypoxia training study
- Diagnosed with AD-dementia or have impaired independent daily functioning; with MMSE <20 and/or CDR ≥1
- Have un-controlled chronic conditions including systolic-diastolic pressures over 150/90 mmHg with medications, diabetes, chronic renal failure (based on the medical history questionnaire), recurrent chest pain, seizures or epilepsies, moderate to severe carotid stenosis or calcification, brain aneurysm, uncontrolled allergic rhinitis, pulmonary fibrosis, emphysema, cancer, infectious disease, atrial fibrillation, regular pre-mature ventricular contractions, myocardial ischemia or infarct, 2nd or 3rd degree atrio-ventricular blockade
- Have severe head injury or traumatic brain injury, stroke (hemorrhagic and/or ischemic)
- Currently have COVID-19
- Unwilling to sign a written consent to participate in this double-blinded placebo-controlled phase I trial
- Unable to visit the lab independently
- Claustrophobic to facemask and hyper-reactive to hypoxia exposure
- Have currently diagnosed depression
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 55 and 79 years old?
This trial is currently available in United States.
- University of North Texas Health Science CenterFort Worth, United StatesContact: Xiangrong Shi, PhDTaking people
About the trial
What the trial wants to find out
This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
The 2 groups in the trial
- IHT TreatmentTreatment being tested
Exposures to hypoxic air (10% O2) up to 5 min intermittent with up to 5 min recovery (breathing room air) per session, 3 sessions/week, up to 12 weeks.
- Sham-IHT controlPlacebo, for comparison
Exposures to normoxic air (21% O2) up to 5 min intermittent with up to 5 min recovery (breathing room air) per session, 3 sessions/week, up to 12 weeks.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intermittent Hypoxia Training: A Novel Therapy for Mild Cognitive Impairment
- Plain-language title
- Breathing low-oxygen air in short bursts for mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05495087, who can take part
- Record updated
- 29 April 2026